Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sub-Lingual Administration of Cannabidiol for Knee Osteoarthritis
NCT06414473Phase 2Recruiting
- Sponsor
- University of Florida
- Start
- Jun 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabidiol in osteoarthritis (OA), sponsored by University of Florida. Primary endpoints: Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events, Theoretical Framework of Acceptability Questionnaire at 1 month and 3 more. Started Jun 2024; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06414473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06414473.